Page last updated: 2024-12-07

4-acetylphenyloxooxazolidinylmethylacetamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-acetylphenyloxooxazolidinylmethylacetamide: structure given in first source; acts on gram+ and anaerobic bacteria [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122686
SCHEMBL ID9521400
MeSH IDM0154441

Synonyms (11)

Synonym
n-[[3-(4-acetylphenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
3-(4-acetylphenyl)-5-acetamidomethyl-2-oxazolidinone
104421-21-8
4-acetylphenyloxooxazolidinylmethylacetamide
n-[[3-(4-acetylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
dup 721
acetamide, n-((3-(4-acetylphenyl)-2-oxo-5-oxazolidinyl)methyl)-, (s)-
SCHEMBL9521400
gtpl10960
DTXSID70908968
n-{[3-(4-acetylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}ethanimidic acid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Oral bioavailability in humans was determined to be 100% and twice daily dosing in humans resulted in blood levels which even at trough values were in excess of the MIC90 for significant Gram-positive pathogens."( The discovery of linezolid, the first oxazolidinone antibacterial agent.
Barbachyn, MR; Ford, CW; Zurenko, GE, 2001
)
0.31

Dosage Studied

ExcerptRelevanceReference
" Oral bioavailability in humans was determined to be 100% and twice daily dosing in humans resulted in blood levels which even at trough values were in excess of the MIC90 for significant Gram-positive pathogens."( The discovery of linezolid, the first oxazolidinone antibacterial agent.
Barbachyn, MR; Ford, CW; Zurenko, GE, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (76.92)18.7374
1990's2 (15.38)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.29 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]